Combined cytotoxic and immune-stimulatory gene therapy for glioma - Authors' reply

Lancet Oncol. 2023 Dec;24(12):e456. doi: 10.1016/S1470-2045(23)00586-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Brain Neoplasms* / genetics
  • Brain Neoplasms* / therapy
  • Genetic Therapy / adverse effects
  • Glioma* / drug therapy
  • Glioma* / therapy
  • Humans

Substances

  • Antineoplastic Agents